Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Genmab reported DKK676M in Selling and Administration Expenses for its fiscal quarter ending in March of 2023.

Selling And Administration Expenses Change
Agios Pharmaceuticals AGIO:US USD 28.37M 4.4M
Almirall SA ALM:SM EUR 124.2M 4.84M
Amarin AMRN:US USD 59.59M 8.54M
Amgen AMGN:US USD 1.26B 210M
AstraZeneca AZN:LN USD 3.2B 331M
Bayer BAYN:GR EUR 4.05B 374M
BioMarin Pharmaceutical BMRN:US USD 223M 22.74M
Bluebird Bio BLUE:US USD 37.35M 6.65M
Demant A/s WDH:DC DKK 5.35B 453M
Exelixis EXEL:US USD 131.4M 12.15M
Fresenius Medical Care FME:GR EUR 782M 172.3M
Galapagos GLPG:NA EUR 58.1M 16.58M
Genmab GEN:DC DKK 676M 245M
GlaxoSmithKline GSK:LN GBP 2.06B 370M
GN Store Nord GN:DC DKK 1.45B 124M
Hikma Pharmaceutical HIK:LN USD 253M 3M
Immunogen IMGN:US USD 40.02M 2.05M
Insmed INSM:US USD 79.91M 6.44M
Merck MRK:GR EUR 1.47B 103M
Novartis NOVN:VX USD 3.4B 298M
Regeneron Pharmaceuticals REGN:US USD 601.1M 59.4M
Roche Holding ROG:VX CHF 6.48B 834M
Seattle Genetics SGEN:US USD 206.44M 9.66M